![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sofosbuvir, Simeprevir, +/- Ribavirin in HCV G1
Protease Inhibitor-Experienced Patients [14/15 SVR 93%]
|
|
|
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Kristen M. Marks*, Ethan M. Weinberg, Sonal Kumar, Carrie Down, Ype P. de Jong, Leah A. Burke, Mary C. Olson, Ira M. Jacobson
Weill Cornell Medical College, New York, NY New York, NY
![CROI1.gif](../images/030915/030915-5/CROI1.gif)
![CROI2.gif](../images/030915/030915-5/CROI2.gif)
![CROI3.gif](../images/030915/030915-5/CROI3.gif)
![CROI4.gif](../images/030915/030915-5/CROI4.gif)
![CROI5.gif](../images/030915/030915-5/CROI5.gif)
![CROI6.gif](../images/030915/030915-5/CROI6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|